Enter Pet Cancer Awareness Month: the perfect time to not only educate your clients about what to look for and stress the importance of regular health and wellness screenings but also expand awareness of available cancer screening tests and resources.<\/p>\n\n\n\n
Read on to learn how our cancer diagnostics offer your practice\u2014and your clients\u2014impactful and affordable diagnosis options.<\/p>\n\n\n\n
Identifying cancer in your canine patients<\/h2>\n\n\n\n
One in four dogs will develop cancer during their lifetime. While certain breeds are more predisposed to cancer, cancer is primarily a disease of aging. Cancer is the leading cause of death among dogs who are beyond middle age, with nearly 50% over the age of 10 dying from the disease. [Source: Veterinary Cancer Society<\/strong><\/span><\/a>]. This means that as our pets live longer due to advances in nutrition, preventive care, and veterinary medicine, their risk of developing cancer naturally increases.<\/p>\n\n\n\n Today, the most prevalent canine cancer is lymphoma, accounting for approximately 24% of all new canine cancer cases, but there are also other types of cancers clinicians should be looking for including hemangiosarcoma and transitional cell carcinoma of the urinary tract to name a few. [Sources: Veterinary Cancer Society<\/span><\/strong><\/a>, and ACVS<\/span><\/strong><\/a>]<\/p>\n\n\n\n Run on Antech\u2019s Element i+\u2122<\/a> <\/span><\/strong>in-house analyzer and requiring only 50\u03bcL of EDTA plasma, Nu.Q\u00ae canine cancer screening test uses innovative technology to measure plasma nucleosome concentration and help determine the current likelihood of common canine cancers, with high (>70%) detection rates for lymphoma and hemangiosarcoma.<\/p>\n\n\n\n Nu.Q\u00ae is a screening tool that should be used for older dogs (\u22657 years) and certain at-risk breeds (\u22654 years). With Nu.Q\u00ae, you can refine your differential list and, in the case of positive results, develop a plan of action before your patient goes home, including further diagnostics.<\/p>\n\n\n\n Low price point and shelf-stable test kits make Nu.Q\u00ae the perfect in-house option for every practice \u2014 and every dog owner. CADET\u2122 BRAF provides early and accurate detection of the most common type of canine urinary tract cancer<\/strong> (known as transitional cell carcinoma or TCC). CADET\u2122 BRAF evaluates canine urine samples for the presence of cells containing the b-raf mutation for TCC. CADET BRAF detects up to 85% of TCC cases. With negative results, (and sufficient sample), BRAF-Plus testing is performed at no extra cost delivering the most informative result from a single submission. And results are not impacted by the presence of red or white blood cells, protein, bacteria, or other potentially interfering substances that can normally impact urine testing.<\/p>\n\n\n\n CADET BRAF testing is ideal for dogs presenting with abnormal urinary signs such as persistent hematuria, stranguria, and recurrent or complicated urinary tract infections. CADET BRAF can also be used as confirmation of TCC diagnosis in cases where cytologic findings are suspicious, but not diagnostic, for malignancy.<\/p>\n\n\n\n This cutting-edge technology is accurate, affordable, and convenient for both veterinarian and pet owners.<\/p>\n\n\n\n Learn more about CADET\u2122 BRAF<\/span><\/strong><\/a><\/p>\n\n\n\n One in five cats will develop cancer at some point in their lives. Although the exact causes of feline cancer are not always clear, several factors can increase a cat\u2019s risk, including genetic predisposition, exposure to environmental toxins, and two of the most common feline viruses \u2014 FeLV (Feline Leukemia Virus) and FIV (Feline Immunodeficiency Virus).<\/p>\n\n\n\n Thankfully, there\u2019s a rapid test for that. Antech’s tr\u016bRapid\u2122 FIV\/FeLV, is an easy-to-use, two-in-one in-house test for Feline Immunodeficiency Virus antibodies and Feline Leukemia Virus antigen.<\/p>\n\n\n\n <\/p>\n\n\n\n tr\u016bRapid\u2122 FIV\/FeLV<\/span><\/a> \u2014 reliable in-house infectious disease testing results in minutes<\/strong>. tr\u016bRapid FIV\/FeLV shows exceptional ability at differentiating between FIV-vaccinated and FIV-infected cats, bringing convenient, accurate, and affordable feline viral testing to any veterinary practice.<\/p>\n\n\n\n![\"\"](\"https:\/\/antechdiagnostics.dv:7890\/wp-content\/uploads\/2025\/10\/Antech-fig6-histiocytic-sarcoma.jpg\")
Nu.Q\u00ae is the industry\u2019s only in-house canine cancer screening test.<\/strong><\/h2>\n\n\n\n
Learn more about Nu.Q on the Element i+<\/span><\/strong><\/a><\/p>\n\n\n\n![\"\"](\"https:\/\/antechdiagnostics.dv:7890\/wp-content\/uploads\/2025\/10\/Antech-Spontaneous-oronasal-ejection-of-neoplastic-nodules-by-dogs-study.jpg\")
<\/figure>\n\n\n\n
<\/p>\n\n\n\nWhat about cancer in feline patients? Screening for common viruses can help<\/h2>\n\n\n\n